Datasheet | August 20, 2021

Navigating The Use Of Controlled Substances In Clinical Trials Using IRT


Sponsor organizations that want to use controlled substances in clinical studies must manage the associated regulatory and logistical requirements. This can be challenging for Emerging BioPharmas with smaller staffs and fewer resources. Regardless of size, every sponsor must use extreme care to meet geographic regulations for the use and distribution of controlled substances in studies.

Cenduit’s leading team of experts in global regulatory compliance and quality build highly configurable and adaptable IRT systems that can easily manage the many requirements of using controlled substances – whether in the U.S., or any other country. Clients receive the confidence of consistent compliance for their supply chain, drug management, and dosing practices.

access the Datasheet!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.

Subscribe to Clinical Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Clinical Leader